Kulvinder Kochar Kaur¹*, Gautam Allahbadia² and Mandeep Singh³

¹Department of Microbiology and Biotechnology, University school of sciences, Gujarat, India
²Scientific Director, Rotunda-A Centre for Human Reproduction, Mumbai, India
³Consultant Neurologist, Swami Satyan and Hospital, Jalandhar, Punjab, India

*Corresponding Author: Kulvinder Kochar Kaur, Scientific Director, Dr Kulvinder Kaur Centre for Human Reproduction, Jalandhar, Punjab, India.

Received: July 14, 2023; Published: March 21, 2023

Abstract

At the time of early pregnancy discrimination amongst an ongoing healthy intrauterine pregnancy (IUP) as well as aberrant situations at the time when transvaginal ultrasound (TVS) is not diagnostic till now; however continues to be of maximum clinical problem. Women with presentation of abdominal pain as well as/or vaginal bleeding would finally be diagnosed as i) IUP ii) a miscarriage or early pregnancy loss (EPL) iii) or an ectopic pregnancy (EP). EPL influences approximately 10-20% pregnancies [1], whereas EP takes place in about 1-2% of pregnancies apart from being the most common etiology of maternal mortality along with morbidity; that is implicated in 6% of pregnancy correlated demises [2]. There is a dramatic variation amongst the proper clinical treatment regarding these 3 results, thus correct diagnosis is essential. At present progesterone along with human chorionic Gonadotropins (HCG) constitute the maximum frequently utilized serum biomarkers regarding the assessment of prognosis of pregnancy once conclusions cant be drawn subsequent to TVS [3].

References

1. Ammon Avalos L., et al. “A systematic review to calculate background miscarriage rates using life table analysis”. Birth Defects Research Part A: Clinical and Molecular Teratology 7 (2012): 725-723.
2. Senapati S., et al. “Predicting first trimester pregnancy outcomes: derivation of a multiple markers test”. Fertility and Sterility2 (2016): 725-732.e3.
3. Whittaker PG., et al. “Gestational hormone trajectories and early pregnancy failure: a reassessment”. Reproductive Biology and Endocrinology 1 (2018): 95.
4. American College of Obstetrician Gynaecologists. “ACOG Practice Bulletin N0-94: medical management of ectopic pregnancy”. Obstetrics and Gynaecology6 (2006): 1479-1485.
5. Gellersen B., et al. “Decidualization of the human endometrium: mechanisms, functions and Clinical perspectives”. Seminars in Reproductive Medicine6 (2007): 445-453.
6. Gellersen B and Brosens JJ. “Cyclic decidualization of the human endometrium in reproductive health and failure”. Endocrine Review6 (2014): 851-905.
7. Altmae S., et al. “Research resource: interaction of human embryo Implantation: identification of gene expression pathways”. Molecular Endocrinology1 (2012): 203-207.
8. Carson DD., et al. “Embryo Implantation”. Developmental Biology2 (2000): 217-237.
9. Kim SM and Kim JS. “A review of mechanisms of Implantation”. Developmental Reproduction 4 (2017): 351-359.
10. Beer LA., et al. “Proteome defined changes in cellular pathways for decidua and trophoblast tissues associated with location and viability of early stage pregnancy”. Reproductive Biology and Endocrinology 20 (2022): 36.

Citation

Citation: Kulvinder Kochar Kaur., et al. “Proteome - Detected Alterations in Cellular Pathways in Pathways Regarding Decidua and Trophoblast Tissues for Discrimination of Ectopic Pregnancy (EP). From Healthy Intrauterine Pregnancy (IUP) and Miscarriage or Early Pregnancy Loss - A - A Short Communication".Acta Scientific Biotechnology 4.3 (2023): 41-48.

Copyright

Copyright: © 2023 Kulvinder Kochar Kaur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.